Form 4: Supernus Pharmaceuticals Executive Exercises Options and Sells Shares Under 10b5-1 Plan

Padmanabh P. Bhatt, a Senior VP at Supernus Pharmaceuticals, exercised stock options and sold shares according to a pre-arranged trading plan.

Summary

• On March 20, 2024, Padmanabh P. Bhatt, Sr. VP of IP and CSO at Supernus Pharmaceuticals, exercised options to acquire 400 shares of common stock at a price of $25.30 per share.
• Simultaneously, Bhatt sold 400 shares of common stock at a price of $35.31 per share.
• These transactions were executed under a pre-arranged 10b5-1 trading plan adopted on September 7, 2023.
• Following these transactions, Bhatt directly owns 8,570 shares of Supernus Pharmaceuticals common stock and 27,236 derivative securities (Employee Stock Options).

Sentiment

Score: 5

Explanation: The sentiment is neutral as the filing simply reports routine transactions under a pre-existing trading plan. There is no indication of positive or negative implications for the company.

Future Outlook

The filing does not contain any forward-looking statements.

Industry Context

Form 4 filings are a routine part of regulatory compliance for corporate insiders and provide transparency into their trading activities. The use of a 10b5-1 plan suggests that the insider's trading activity is pre-planned and not based on any material non-public information.

Comparison to Industry Standards

• Form 4 filings are standard practice across all publicly traded companies in the US and are required by the SEC.
• The use of 10b5-1 trading plans is a common strategy employed by corporate insiders to avoid accusations of insider trading, aligning with best practices in corporate governance.
• Similar filings are regularly made by executives at comparable pharmaceutical companies like Jazz Pharmaceuticals and Alkermes, reflecting standard compliance procedures.

Stakeholder Impact

• The transactions are unlikely to have a significant impact on shareholders, as they are part of a pre-arranged trading plan and involve a relatively small number of shares.

Key Dates